Gene · 5649
Papers3,990
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,990
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers in glioblastoma and degenerative CNS diseases: defining new advances in clinical usefulness and therapeutic molecular target. | Front Mol Biosci | 2025 | 40171042 | PubTator, text mining | PubMed |
| New Insights Into the Neural Consequences of Synthetic Cannabinoids During Adolescence: The Critical Role of Reelin at Prefrontal Synapses. | Biol Psychiatry Glob Open Sci | 2025 | 40160991 | PubTator, text mining | PubMed |
| CellGAT: A GAT-Based Method for Constructing a Cell Communication Network Integrating Multiomics Information. | Biomolecules | 2025 | 40149878 | PubTator, text mining | PubMed |
| Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. | Pharmaceuticals (Basel) | 2025 | 40143207 | PubTator, text mining | PubMed |
| Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes. | Proc Natl Acad Sci U S A | 2025 | 40073057 | PubTator, text mining | PubMed |
| Beyond the brain: Reelin's emerging role in cancer pathways. | Pathol Res Pract | 2025 | 40068281 | PubTator, text mining | PubMed |
| Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy. | Neuropsychiatr Dis Treat | 2025 | 40045946 | PubTator, text mining | PubMed |
| Glutamatergic argonaute2 promotes the formation of the neurovascular unit in mice. | Sci Signal | 2025 | 39999211 | PubTator, text mining | PubMed |
| The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: New mechanism-based therapeutic options. | Epilepsia | 2025 | 39985505 | PubTator, text mining | PubMed |
| Regulatory mechanism of Reelin activity: a platform for exploiting Reelin as a therapeutic agent. | Front Mol Neurosci | 2025 | 39931643 | PubTator, text mining | PubMed |
| Dab1 expression level controls Reelin-induced PI3K-Akt activation in early GABAergic neurons. | Biochem Biophys Res Commun | 2025 | 39919390 | PubTator, text mining | PubMed |
| Expression Profiling of Reelin (RELN) Gene in Patients With Schizophrenia from North Karnataka. | Cureus | 2025 | 39897195 | PubTator, text mining | PubMed |
| Shared molecular signature in Alzheimer's disease and schizophrenia: A systematic review of the reelin signaling pathway. | Neurosci Biobehav Rev | 2025 | 39894421 | PubTator, text mining | PubMed |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer's disease. | bioRxiv | 2025 | 39868232 | PubTator, text mining | PubMed |
| Intraneuronal binding of amyloid beta with reelin-Implications for the onset of Alzheimer's disease. | PLoS Comput Biol | 2025 | 39775030 | PubTator, text mining | PubMed |
Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children? | Brain Behav Immun | 2025 | 39617068 | PubTator, text mining | PubMed |
| Upregulation of olfactory receptors and neuronal-associated genes highlights complex immune and neuronal dysregulation in Long COVID patients. | Brain Behav Immun | 2025 | 39615603 | PubTator, text mining | PubMed |
| Exosomes Released from Senescent Cells and Circulatory Exosomes Isolated from Human Plasma Reveal Aging-associated Proteomic and Lipid Signatures. | bioRxiv | 2025 | 38979258 | PubTator, text mining | PubMed |
| Single-Cell Nuclear Sequencing Atlas Revealed the Induction of Parkinson's Disease by RELN+ Neuron 3 and the Gene Regulatory Network of MSRA. | Curr Med Chem | 2025 | 38561620 | PubTator, text mining | PubMed |
| Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression. | bioRxiv | 2025 | 38168363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5649/papers?page=7